{
    "eid": "2-s2.0-85057083547",
    "title": "Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II",
    "cover-date": "2018-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "acute coronary syndrome",
        "Cholesterol",
        "coronary heart disease",
        "lipids",
        "myocardial infarction",
        "statins"
    ],
    "authors": [
        "Kian Keong Poh",
        "Baishali Ambegaonkar",
        "Carl A. Baxter",
        "Philippe Brudi",
        "Wacin Buddhari",
        "Fu Tien Chiang",
        "Martin Horack",
        "Yangsoo Jang",
        "Brett Johnson",
        "Dominik Lautsch",
        "J. P.S. Sawhney",
        "Ami Vyas",
        "Bryan P. Yan",
        "Anselm K. Gitt"
    ],
    "citedby-count": 25,
    "ref-count": 44,
    "ref-list": [
        "Cardiovascular disease epidemiology in Asia: an overview",
        "Trends in coronary heart disease epidemiology in India",
        "Global shifts in cardiovascular disease, the epidemiologic transition, and other contributing factors: toward a new practice of global health cardiology",
        "Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015",
        "Demographic and epidemiologic drivers of global cardiovascular mortality",
        "Urban environments and obesity in southeast Asia: a systematic review, meta-analysis and meta-regression",
        "Epidemiology of cardiovascular risk factors in Asian countries",
        "The rise of chronic non-communicable diseases in southeast Asia: time for action",
        "Cholesterol, coronary heart disease, and stroke in the Asia Pacific region",
        "A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region",
        "2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines",
        "ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)",
        "Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients",
        "et al. Suboptimal control of lipid levels: results from 29 countries participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS)",
        "Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey",
        "A systematic review and meta-analysis on the therapeutic equivalence of statins",
        "Simplifying the audit of risk factor recording and control: a report from an international study in 11 countries",
        "Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey",
        "EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries",
        "Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology",
        "New insights into the pathophysiology of dyslipidemia in type 2 diabetes",
        "EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries",
        "The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre",
        "Determinants for achieving the LDL cholesterol target of lipid control for secondary prevention of cardiovascular events in Taiwan",
        "Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey",
        "Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong",
        "Lipid goal attainment and prescription behavior in Asian patients with acute coronary syndromes: experience from a tertiary hospital",
        "Cardiovascular disease (CVD) risk factors in older adults \u2013 perception and reality",
        "Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older",
        "Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction",
        "Ezetimibe added to statin therapy after acute coronary syndromes",
        "Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial",
        "Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement",
        "Safety of atorvastatin in Asian patients within clinical trials",
        "Efficacy and safety of the intensive dose of rosuvastatin 40 mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease \u2013 ROSUVEES-2",
        "The difference between Asian and Western in the effect of LDL cholesterol lowering therapy on coronary atherosclerotic plaque: a meta-analysis report",
        "Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment",
        "2017 Taiwan lipid guidelines for high risk patients",
        "2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines",
        "Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy",
        "Ministry of Health Clinical Practice Guidelines: Lipids",
        "Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1 \u2013 executive summary",
        "2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines \u2013 executive summary: Dyslipidemia Guidelines 2015"
    ],
    "affiliation": [
        {
            "affiliation-city": "Singapore City",
            "@id": "60106366",
            "affilname": "National University Health System",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60106366",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60105553",
            "affilname": "Merck Sharp &amp; Dohme, Australia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60026680",
            "affilname": "NUS Yong Loo Lin School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026680",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Ludwigshafen",
            "@id": "60022960",
            "affilname": "Klinikum Ludwigshafen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022960",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60016912",
            "affilname": "Yonsei University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016912",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Kingston",
            "@id": "60010806",
            "affilname": "The University of Rhode Island",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010806",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rahway",
            "@id": "60007995",
            "affilname": "Merck &amp; Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Brunswick",
            "@id": "115396715",
            "affilname": "Rutgers University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/115396715",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New Delhi",
            "@id": "112648889",
            "affilname": "Sri Ganga Ram Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112648889",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Hoddesdon",
            "@id": "112578413",
            "affilname": "MSD Ltd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112578413",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Ludwigshafen",
            "@id": "100527874",
            "affilname": "Stiftung Institut f\u00fcr Herzinfarktforschung",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100527874",
            "affiliation-country": "Germany"
        }
    ],
    "funding": [
        "Merck & Co., Inc."
    ]
}